Deep Dive

Atlas Research is an AI-powered research environment designed to advance reproducible computational science. The platform provides a unified workspace that combines code notebooks, reference management, and paper-writing tools, drawing inspiration from Donald Knuth’s concept of literate programming.

Key features include AI assistance for code refinement and manuscript editing, enabling users to streamline both computational and scholarly workflows. By consolidating multiple applications into a single platform, Atlas Research simplifies project management and enhances productivity.

The platform is tailored for a diverse audience—including academics, data scientists, machine learning engineers, and quantitative finance professionals—who require seamless integration of coding, research, and publication processes. Atlas Research positions itself as a comprehensive solution for efficient, reproducible, and collaborative computational research.

Creator: http://santarovich.tilda.ws/

Donations: https://paypal.me/OlgaSantarovich

Archestra is an open-source platform designed to help enterprises securely integrate AI agents with their internal data while preventing “rogue AI” behavior. Central to the platform is the Model Context Protocol (MCP) runtime, which safeguards AI interactions, complemented by features such as prompt injection prevention and supply chain analysis for AI agent packages.

Archestra recently raised €2.8 million in pre-Seed funding, reflecting strong investor confidence in its mission to provide robust security and governance infrastructure for autonomous AI within businesses. By leveraging advancements like Anthropic’s Model Context Protocol, Archestra enables safe, scalable AI-to-data connectivity across organizations.

The platform is designed to make AI agents accessible and secure for a wide range of employees—from engineers and data scientists to HR and operations teams—ensuring businesses can harness AI safely, efficiently, and responsibly.

Creator: http://santarovich.tilda.ws/

Donations: https://paypal.me/OlgaSantarovich

Plancraft is a cloud-based software platform designed to streamline operations for tradespeople, including roofers, painters, and carpenters. By digitalizing traditionally paper-heavy workflows, Plancraft simplifies tasks such as generating offers and invoices, tracking time, and managing projects, helping businesses operate more efficiently and profitably.

Key features include mobile measurement tools, real-time communication between site and office, and post-calculation functionalities, all aimed at saving time and improving organization. User testimonials highlight tangible benefits, including faster project turnaround, better collaboration, and enhanced operational control.

Plancraft is tailored for craft businesses of all sizes and experience levels, offering specialized programs for students and new founders, positioning it as a comprehensive solution for modernizing trade operations.

Creator: http://santarovich.tilda.ws/

Donations: https://paypal.me/OlgaSantarovich

Sateliot, a Spanish SpaceTech company founded in 2018, is on a mission to become the world’s first 5G-IoT telecommunications operator from space. By deploying a constellation of low-Earth orbit (LEO) satellites, the company aims to deliver seamless NB-IoT connectivity to standard devices worldwide—bridging the digital divide in industries where remote coverage is critical, such as defense, agriculture, and logistics.

In its latest milestone, Sateliot secured €70 million in Series B funding to accelerate the deployment of over 100 satellites. The company has already launched six satellites and signed significant commercial contracts, reinforcing both market demand and technological validation.

Sateliot projects €1 billion in revenue by 2030, backed by a strong leadership team, strategic partnerships, and a scalable approach designed to integrate directly with existing telecom networks. Its vision is to make global IoT connectivity affordable and accessible, unlocking new opportunities for smart applications across every sector.

Podcast creator page: http://santarovich.tilda.ws/

Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Aufinity Group, a Cologne-based FinTech startup specializing in digital payment management for the automotive sector, including vehicle sales and after-sales services. Founded in 2018, the company offers products like 'bezahl.de' for German-speaking markets and 'Aufinity' internationally, aiming to streamline payment processes, enhance liquidity, and improve customer experience for car dealerships and OEMs. A recent Series C funding round of €23 million, led by BlackFin Capital Partners with re-investment from PayPal Ventures and Seaya Ventures, will fuel Aufinity Group's European expansion, with new branches already established in Madrid and Rome. The sources highlight the company's significant market penetration in Germany, managing over €7 billion annually, and its strategic focus on accelerating growth and forging partnerships with leading Original Equipment Manufacturers across Europe.

Podcast creator page: http://santarovich.tilda.ws/

Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Specter automation, a ConstructionTech startup based in Cologne, has secured over €5 million in seed funding to advance its 3D site management software. This cloud-based platform aims to digitize construction site execution by using 3D models to streamline planning, communication, and documentation, addressing the construction industry's significant untapped data. The funding will support scaling their team and global expansion. Specter's software integrates with existing workflows, providing real-time insights to improve efficiency and reduce costs for various stakeholders in the construction process.

Podcast creator page: http://santarovich.tilda.ws/

Support our podcast with your donations: https://paypal.me/OlgaSantarovich

enova365, a comprehensive Enterprise Resource Planning (ERP) software system designed for managing, automating, and digitizing company processes. It details various modules and solutions, including HR, finance, sales, warehousing, and business intelligence, applicable across diverse industries and business sizes. The source emphasizes the system's flexibility, scalability, regulatory compliance, and integration capabilities. Additionally, it provides contact information, case studies, pricing details, and options for implementation and support, positioning enova365 as an all-encompassing solution for business management.

Podcast creator page: http://santarovich.tilda.ws/

Support our podcast with your donations: https://paypal.me/OlgaSantarovich

CRISPR Therapeutics, a biotechnology company focused on developing gene-editing medicines. The Wikipedia entry offers a comprehensive overview of the company, detailing its founding in 2013 by individuals including Nobel laureate Emmanuelle Charpentier, its headquarters in Switzerland, and its public listing on NASDAQ. It highlights key collaborations with companies like Vertex Pharmaceuticals and mentions their lead product, exa-cel (CASGEVY™), which received FDA approval in December 2023 for sickle cell disease and beta thalassemia. The official company website reinforces these points, emphasizing their decade of innovation and diverse pipeline spanning hemoglobinopathies, oncology, autoimmune diseases, and regenerative medicine, while also touting exa-cel as the first-ever approved CRISPR-based therapy. Both sources collectively portray CRISPR Therapeutics as a pioneer in gene-editing technology, committed to transforming patient lives through groundbreaking therapies.

Podcast creator page: http://santarovich.tilda.ws/

Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Cathie Wood, a prominent investor overseeing nearly $30 billion, who shares her insights on the future of investing. Wood highlights Artificial Intelligence (AI) as the most significant technological disruption in history, predicting massive investment and job opportunities for those on the "right side of change." She champions Tesla as the largest AI project on Earth, forecasting its stock to reach $2,600 in five years, primarily due to its robotaxi platform and future humanoid robots. Additionally, Wood discusses the potential of Bitcoin as a new asset class, projecting its value to reach $1.5 million by 2030, driven by institutional adoption and its role as a global monetary system. Her firm, ARK Invest, focuses on disruptive innovation across five key platforms: robotics, energy storage, artificial intelligence, blockchain technology, and multiomic sequencing, offering ETFs for investors to gain exposure to these transformative areas.

Podcast creator page: http://santarovich.tilda.ws/

Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Vertex Pharmaceuticals is a company that invests in scientific innovation to create transformative medicines for people with serious diseases. Their primary focus is on discovering, developing, and producing innovative medicines so that individuals with serious diseases can lead better lives.

Key aspects of Vertex Pharmaceuticals include:

• ​Mission and Patient Focus: The company is built on an inclusive culture that unites individuals from various fields, all striving towards the singular goal of improving the lives of people with serious diseases. They are "relentless in [their] quest to improve the lives of people living with serious diseases". This commitment guides their efforts, particularly in areas like cystic fibrosis, where they are "uncompromising" in their dedication to patients.
• ​Scientific Approach: Vertex's scientists approach challenges by seeing "the impossible as a good place to start" for scientific discovery. They are deeply committed to scientific innovation.
• ​Impact and Value: Through their transformative medicines for patients, Vertex aims to drive value for their company, shareholders, and society.
• ​Patient Support and Community Engagement: Beyond developing medicines, Vertex provides comprehensive programs that offer personalized support throughout a patient's treatment journey with a Vertex medicine. They also actively engage with patient communities, such as working with the kidney community to ensure their voices are represented and engaging with the sickle cell disease community.
• ​Clinical Research: They conduct clinical trials, noting that volunteers who participate in these trials help make new medicines a reality.
• ​Corporate Responsibility: Their innovation process is guided by values such as fearlessness, diversity, collaboration, and a commitment to patients, which also fuel their corporate responsibility efforts. They regularly report on how they operate their business responsibly and their positive impact on patients, employees, communities, and the environment.

Podcast creator page: http://santarovich.tilda.ws/

Support our podcast with your donations: https://paypal.me/OlgaSantarovich